United States
US 12,702,695 B2
Formulated and/or co-formulated liposome compositions containing toll-like receptor (“TLR”) agonist prodrugs useful in the treatment of cancer and methods thereof
US 12,702,695 B2 is a granted patent from the United States Patent and Trademark Office (USPTO), dated 2026-08-11. Applicant: Nammi Therapeutics, Inc. Its PDF downloads from this page without an account, up to 5 a day.
- Applicant
- Nammi Therapeutics, Inc.
- Inventors
- David Stover; Dhruba Bharali; Bruce A. Hay; Tahmineh Safaie
- Publication date
- 2026-08-11
- Filing date
- 2023-03-10
- Document type
- B2 Granted patent
- Also written as
- US 12,702,695 B2 · US12702695 · 12702695
Abstract
Formulated and/or co-formulated liposomes comprising TLR prodrugs and/or TLR Lipid Moieties and methods of making the liposomes are disclosed herein. The TLR prodrug compositions comprise a drug moiety, a lipid moiety, and linkage unit that inhibit Toll-Like Receptor (e.g., TLR1/2, TLR4, and/or TLR7). The TLR prodrugs can be formulated and/or co-formulated into a liposome to provide a method of treating cancer, immunological disorders, and other disease by utilizing a targeted drug delivery vehicle.
The opening of the abstract. The full text is in the PDF.
No account needed: 5 free downloads a day (5 left today). Batch downloads and Office Action citations need a free account.
Patent office website: United States Patent and Trademark Office (USPTO)
Look up another patent
Need many patents at once?
Paste a whole list of numbers. DownloadPatent finds the right version of each and packs the PDFs into one ZIP.
Sign up free